Respiratory Medicine
Volume 104, Issue 5 , Pages 668-674, May 2010

Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial

  • Duncan B. Richards

      Affiliations

    • Drug Discovery, GlaxoSmithKline, Stevenage CB2 2GG, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1223 296159.
    • ,
  • Philippe Bareille

      Affiliations

    • Drug Discovery, GlaxoSmithKline, Stevenage CB2 2GG, UK
    • ,
  • Emma L. Lindo

      Affiliations

    • Discovery Biometrics, GlaxoSmithKline, Greenford, UK
    • ,
  • Dean Quinn

      Affiliations

    • P3 Research, Bowen Hospital, Wellington, New Zealand
    • ,
  • Stuart N. Farrow

      Affiliations

    • Drug Discovery, GlaxoSmithKline, Stevenage CB2 2GG, UK

Received 23 July 2009; accepted 10 November 2009. published online 30 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(09)00370-9

doi:10.1016/j.rmed.2009.11.006

Respiratory Medicine
Volume 104, Issue 5 , Pages 668-674, May 2010

Article Tools

* Image Usage & Resolution